Loading...
Images of Toshiyuki Takasu
(0 from 0 )Interests
Toshiyuki Takasu - Patents
www.freshpatents.com
Toshiyuki Takasu patents Recent bibliographic sampling of Toshiyuki Takasu patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Effects of the SGLT2 inhibitor ipragliflozin on food intake,...
www.em-consulte.com
Atsuo Tahara , Yoshinori Kondo, Toshiyuki Takasu, Hiroshi Tomiyama. a Candidate Discovery Science Laboratories, Astellas Pharma Inc., Tsukuba, Ibaraki, ...
Business Profiles
Researchgate: Toshiyuki Takasu
Tokyo, Japan
patentbuddy: Toshiyuki Takasu
ASTELLAS PHARMA INC., Tsukuba-shi, JP
Property
BRPI cristal na forma alfa de acetanilida e composição...
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Books & Literature
Effect of Repetitive Glucose Spike and Hypoglycaemia on...
doaj.org
Information about the open-access article 'Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice' in...
Index of Patents Issued from the United States Patent and ...books.google.de › books
books.google.de
Takaoka , Hikaru ; Inoshita , Teruaki ; Fukuda , Takashi ; and Toga , HitoKomatsu , Toshiyuki ; Takasu , Yoshio ; Fujii , Motoharu ; and Sugishi , to Kabushiki ...
Index of Patents Issued from the United States Patent Officebooks.google.de › books
books.google.de
,000. y Komatsu, Toshiyuki; Takasu, Yoshio; Fujii, Motoharu; and Sugiura, Susumu, 4, 163,892, Cl, 219– Takasuga, Yutaka, to Bridgestone Tire ...
Official Gazette of the United States Patent and Trademark ...books.google.de › books
books.google.de
Okumura, Hisatake: See— Muroi, Toshiyuki; Takasu, Toshikazu; Ozeki, Yuji; and Okumura, Hisatake, 6,454,144, Cl Okumura, Katsuya: See— ...
Related Documents
ASP1941, a Novel, Potent and Selective SGLT2 Inhibitor, Improves...
professional.diabetes.org
Author: TOSHIYUKI TAKASU. ASP1941, a Novel, Potent and Selective SGLT2 Inhibitor, Improves Hemoglobin A1c and Symptoms of Diabetes in Animal Models ...
OASIS
www.abstractsonline.com
EIJI KUROSAKI, TOSHIYUKI TAKASU, SHUNJI YAMAZAKI, KUMI KOIDE, NORIAKI MAEDA, ANN HASTINGS, QUN LI, Ibaraki, Japan, Leiderdorp, Netherlands: Abstract:
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan,...
www.scienceopen.com
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-Ay Diabetic Mice. Authors: Toshiyuki Takasu, Hirotoshi ...
Antihyperglycemic effect of ipragliflozin, a sodium‐glucose...
www.deepdyve.com
Toshiyuki Takasu, Yuka Hayashizaki, Atsuo Tahara, Eiji Kurosaki and Shoji Takakura. Tsukuba Research Center, Drug Discovery Research, Astellas Pharma, ...
Scientific Publications
An Angiotensin II (Ang II) Type 1 Receptor Blocker NCBIwww.ncbi.nlm.nih.gov › pmc › articles › PMC
www.ncbi.nlm.nih.gov
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-Ay Diabetic Mice. Toshiyuki Takasu, Hirotoshi Kakuta, [.
Toshiyuki Takasu – ScienceOpen
www.scienceopen.com
We evaluated the pharmacological characteristics of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]-ethyl} acetanilide (YM178). YM
Inhibitory effects of botulinum toxin on 5-HT1C receptor-induced Cl−...
www.sciencedirect.com
Michihisa Tohda a Toshiyuki Takasu a Junji Nakamura a, Narito Morii b, Shuh Narumiya b and Yasuyuki Nomura a,c,, a Department of Pharmacology, Faculty of ...
Publications
Characterization and comparison of sodium-glucose cotransporter 2...
core.ac.uk
By Atsuo Tahara, Toshiyuki Takasu, Masanori Yokono, Masakazu Imamura and Eiji Kurosaki. Download PDF (2 MB) ...
Publications Authored by Toshiyuki Takasu | PubFacts
www.pubfacts.com
Publications Authored by Toshiyuki Takasu
Effect of Repetitive Glucose Spike and Hindawiwww.hindawi.com › journals › ije
www.hindawi.com
Kenichi Nakajima,1 Tomoya Mita ,1,2 Yusuke Osonoi,1 Kosuke Azuma,1Toshiyuki Takasu,3 Yoshio Fujitani,1 and Hirotaka Watada1,2,4,5. 1Department of ...
Effects of the SGLT2 inhibitor ipragliflozin on various diabetic...
link.springer.com
Diabetic nephropathy is the leading cause of end-stage renal disease and is associated with high-cardiovascular risk and significant morbidity and mortalit
Miscellaneous
CA A1 - Remedy for overactive bladder comprising acetic …...
patents.google.com
Other languages: English: French; Inventor: Toshiyuki Takasu: Shuichi Sato: Masashi Ukai: Tatsuya Maruyama: Masayuki Shibasaki; Current Assignee.
Toshiyuki Takasu (@104designfactory) instagram media ...instabusters.net › photo-video
picboon.com
Toshiyuki Takasu (@104designfactory) instagram media posted 11 months ago | instabusters.net グラストラッカーBB少しずつ製作中☆ ＃グラストラッカー ＃グラス ...
Hyperlipidemias: Takasu, Toshiyuki - Expertscape.com
expertscape.com
Toshiyuki Takasu has special expertise in Hyperlipidemias
Urinary Bladder: Takasu, Toshiyuki - Expertscape.com
www.expertscape.com
Toshiyuki Takasu has special expertise in Urinary Bladder
Toshiyuki Takasu
issx.confex.com
Astellas Pharma Inc. Applied Pharmacology Research Laboratories 21 Miyukigaoka, Tsukuba-shi. Ibaraki Japan. Papers to which this person is assigned:
Toshiyuki Takasu
www.infona.pl
Dipeptidyl peptidase (DPP)-IV is involved in the inactivation of glucagon-like peptide-1 (GLP-1), a potent insulinotropic peptide. Thus, DPP-IV ...
(12) Reissued Patent (10) Patent Number: US RE44,872 E. Takasu et al....
docplayer.net
(75) Inventors: Toshiyuki Takasu, Tsukubamirai (JP); 6, B Fabiano et al. Shuichi Sato, Tsukuba (JP); Masashi 6,291,491 B1 9,
DE D1 - Mittel zur behandlung von blasenhyperaktivität mit...
patents.google.com
Toshiyuki Takasu Shuichi Sato Masashi Ukai Tatsuya Maruyama Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and ...
US A1 - Remedy for overactive bladder comprising acetic...
patents.google.com
Toshiyuki Takasu, Shuichi Sato, Masashi Ukai, Tatsuya Maruyama: Original Assignee: Astellas Pharma Inc. Export Citation: BiBTeX, EndNote, RefMan:
Effect of...
jpet.aspetjournals.org
Dr. Toshiyuki Takasu, Pharmacology Research Laboratories, ... (2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide; CHO, Chinese hamster ovary; I.A.,
Characterization and comparison of sodium-glucose ...cyberleninka.org › article
cyberleninka.org
Atsuo Tahara*, Toshiyuki Takasu, Masanori Yokono, Masakazu Imamura, Eiji Kurosaki. Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan.
WO A3 - Amorphous mirabegron and processes for crystal forms...
patents.google.com
Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes...
WO A1 - α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE...
patents.google.com
Inventeurs, Souichirou Kawazoe, Kenichirou Sakamoto, Yuji Awamura, Tatsuya Maruyama, Takayuki Suzuki, Kenichi Onda, Toshiyuki Takasu. Déposant ...
EP A4 - Composition pharmaceutique pour le traitement de...
patents.google.com
... EP-A , EP , EP , EP A4, EP A4. Inventors, Eiji Kurosaki, Toshiyuki Takasu, Noriaki Maeda, Shunji Yamazaki.
Effects of the SGLT2 inhibitor ipragliflozin on food intake,...
schlr.cnki.net
Atsuo Tahara,Toshiyuki Takasu,Masanori Yokono,Masakazu Imamura,Eiji Kurosaki. Journal of Pharmacological Sciences (3); [2]Effects of SGLT2 selective ...
Antihyperglycemic effect of ipragliflozin, a sodium‐glucose...
www.bionity.com
Authors: Toshiyuki Takasu, Yuka Hayashizaki, Atsuo Tahara, Eiji Kurosaki, Shoji Takakura. Journal: Clinical and Experimental Pharmacology ...
Effects of the combination of SGLT2 selective inhibitor ipragliflozin...
www.infona.pl
Atsuo Tahara, Toshiyuki Takasu, Masanori Yokono, Masakazu Imamura, Eiji Kurosaki · Details · Contributors · Fields of ... Toshiyuki Takasu. Astellas Pharma Inc.
Mamoru-kun ni Megami no Shukufuku wo!: The Art of Toshiyuki Takasu -...
gallery.minitokyo.net
The Art of Toshiyuki Takasu. Toshiyuki Satou Mangaka Zexcs Studio Mamoru-kun ni Megami no Shukufuku wo! Series Ayako Takasu Character Mamoru Yoshimura Character
Effect of YM178, a Novel Selective β3-Adrenoceptor Agonist ...jpet.aspetjournals.org › content › early › › jpet
jpet.aspetjournals.org
Toshiyuki Takasu, Masashi Ukai, Shuichi Sato, Tetsuo Matsui, Itsuro Nagase, Tatsuya Maruyama, Masao Sasamata, Keiji Miyata, Hisashi ...
Effects of the SGLT2 inhibitor ipragliflozin on Altmetricwww.altmetric.com › details
www.altmetric.com
Atsuo Tahara, Toshiyuki Takasu. Abstract. Diabetic nephropathy is the leading cause of end-stage renal disease and is associated with high-cardiovascular risk ...
Related search requests for Toshiyuki Takasu
| Shunji Yamazaki Masakazu Imamura Masao Sasamata | Noriaki Maeda Shuichi Sato Masashi Ukai | Tatsuya Maruyama |
People Forename "Toshiyuki" (831) Name "Takasu" (194) |
sorted by relevance / date